Gastrointestinal (GI): NSAIDs that block COX-1 action have correlations with GI problems because of the inhibition of your synthesis of gastroprotective agents like PGE2 along with other prostaglandins. This inhibition results in lowered mucin output by gastric epithelial cells, fewer bicarbonate secretion, and fewer epithelial cell turnover, among the other https://danielg924div1.sunderwiki.com/user